ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Infection"

  • Abstract Number: 0082 • ACR Convergence 2020

    Diffuse Sclerosing Osteomyelitis of the Jaw: An Underdiagnosed Disease in Maxillofacial Surgery Department

    Pauline Preuss1, Hélios Bertin1, Pierre Corre1 and Benoit Le Goff2, 1Nantes University Hospital, Nantes, France, 2Nantes University Hospital, Nantes, Pays de la Loire, France

    Background/Purpose: Diffuse sclerosing osteomyelitis of the jaw is a rare and under-recognized disease. Many authors include this diagnosis in the spectrum of aseptic osteitis sometimes…
  • Abstract Number: 0628 • ACR Convergence 2020

    Factors Associated with Knee Osteoarthritis in an Outpatient HIV-1 Clinic over a 26 Year Interval

    Benjamin Naovarat1, Francis Williams1, Jonathan Dau2, Marka Lyons3, Binh Nguyen4, Gloria Salazar3 and John Reveille5, 1The University of Texas McGovern Medical School, Houston, TX, 2Massachusetts General Hospital, Harvard Medical School, Boston, MA, 3University of Texas Houston, McGovern Medical School, Division of Rheumatology and Clinical Immunogenetics, Houston, TX, 4The University of Texas-McGovern Medical School, Houston, TX, 5Department of Internal Medicine, University of Texas, Houston, TX

    Background/Purpose: With the advent of combined antiretroviral therapy (cART), patients with HIV-1 began living longer and started to develop diseases associated with aging such as…
  • Abstract Number: 1277 • ACR Convergence 2020

    Low Cost Composite Markers to Differentiate Infection from Disease Activity in a Febrile Patient with Systemic Lupus Erythematosus

    Pankti Mehta1, Komal Singh1, Amita Aggarwal1 and Seema Sharma1, 1Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India

    Background/Purpose: Patients with Systemic Lupus Erythematosus (SLE) are at an increased risk of infection owing to immunosuppressive therapy along with coexistent immune dysregulation. It is…
  • Abstract Number: 0091 • ACR Convergence 2020

    Helicobacter Pylori Infection, Autoimmune Disease and Paraproteinemia Influence the Presentation of a Cohort of 150 Pernicious Anemia Patients Diagnosed in a Rheumatology Clinic

    Michael Lovy1, Norma Daniela Aguirre Vega1 and Crystal Escobar1, 1Desert Oasis Healthcare, Palm Springs, CA

    Background/Purpose: The most familiar presentation of pernicious anemia is an elderly Northern European woman with hematologic and neurologic manifestations.  More recently the influence of Helicobacter…
  • Abstract Number: 0630 • ACR Convergence 2020

    “No Benefit from a Strict Immobilization in Vertebral Osteomyelitis” Vertebral Immobilization and Neurological Complication in Acute Pyogenic Vertebral Osteomyelitis: SPONDIMMO, a Prospective Cohort of 250 Patients

    Adrien Le Pluart1, COIFFIER Guillaume2, Christelle Darrieutort1, CORMIER Grégoire3, GODOT Sophie4, Sebastien Ottaviani5, Gaetane Nocturne6, MEROT Oriane7, COUDERC Marion8, HOPPE Emmanuel9, MULLEMAN Denis10, Benoit Le Goff11 and Geraldine Bart12, 1Nantes University Hospital Center, Nantes, France, 2Rennes University Hospital Center, Rennes, France, 3La Roche Sur Yon Hospital Center, La Roche Sur Yon, France, 4Paris Croix Saint Simon Hospital Center, Paris, France, 5Rheumatology Department, Bichat hospital, APHP, Paris, France, 6Rheumatology Department, Bicetre Hospital, APHP, France, Le Kremlin-Bicêtre, France, 7Saint Nazaire Hospital Center, Saint-Nazaire, Pays de la Loire, France, 8Clermont Ferrant University Hospital Center, Clermont Ferrand, France, 9Angers University Hospital Center, Angers, France, 10Tours University Hospital Center, Tours, France, 11Nantes University Hospital, Nantes, Pays de la Loire, France, 12Rennes University Hospital Center, Rennes, Bretagne, France

    Background/Purpose: Vertebral osteomyelitis (VO) can be associated with neurological complications. We showed in a previous study that they occurred in 40% of patients with VO.…
  • Abstract Number: 1465 • ACR Convergence 2020

    The Impact of the Combined Vaccination Scheme Against Streptococcus Pneumoniae on the Incidence of Related Infections in Patients with Rheumatoid Arthritis Treated with Biologic or Targeted Synthetic DMARD: Data from BIOBADASER 3.0

    Sebastian Rodriguez-Garcia1, Carlos Sanchez-Piedra2, Raul Castellanos-Moreira3, Dolores Ruiz-Montesinos4, Victoria Hernandez5, Manuel Pombo-Suarez6, Fernando Sanchez-Alonso2, Loreto Carmona7 and JJ Gómez-Reino8, 1La Princesa University Hospital, Madrid, Spain, 2Biobadaser, Research Unit, Sociedad Española de Reumatología, Madrid, Spain, 3Hospital Clinic of Barcelona, Barcelona, Spain, 4Hospital Virgen Macarena, Sevilla, Spain, 5Hospital Clínic Barcelona, Barcelona, Spain, 6Hospital Clínico de Santiago, Santiago de Compostela, Spain, 7Instituto de Salud Musculoesquelética, Madrid, Spain, 8IDIS-CHUS - Rheumatology Group, Santiago de Compostela, Spain

    Background/Purpose: Respiratory infections are among the leading causes of hospitalization in rheumatoid arthritis (RA) and Streptococcus Pneumoniae (SP) is one of the most frequent pathogens…
  • Abstract Number: 0100 • ACR Convergence 2020

    Concordance Between the QuantiFERON-TB Gold In-Tube and Tuberculin Test for the Diagnosis of Latent Tuberculosis Infection in Patients with Rheumatic Diseases

    Cristobal Pavez Perales1, Ana Quiles Rocher2, Elena Grau Garcia3, Marta De la Rubia Navarro1, Samuel Leal Rodriguez4, Roxana Gonzalez Mazario1, Jorge Juan Fragio Gil1, Cristina Alcañiz Escandell3, Jose Ivorra Cortes1, Inmaculada Chalmeta Verdejo1, Luis Gonzalez Puig5, Isabel Martinez Cordellat1, Rosa Negueroles Albuixech1, Jose Eloy Oller Rodriguez1, Francisco Miguel Ortiz Sanjuan4, Elvira Vicens Bernabeu4, Carmen Najera Herranz1, Ines Canovas Olmos1 and Jose Andres Roman Ivorra1, 1Rheumatology Department. HUP La Fe, Valencia, Spain, 2Medical School, UCV, Valencia, Valencia, Spain, 3Rheumatology Department. HUP La Fe, Valencia, Comunidad Valenciana, Spain, 4Rheumatology Department, HUP La Fe, Valencia, Spain, 5Rheumatology Department. HUP La Fe, Torrente ( Valencia), Spain

    Background/Purpose: Patients with rheumatic diseases (RD) are at higher risk of latent tuberculosis infection (LTBI) reactivation. To detect and treat it before starting treatment, especially with biological therapies, decrease the reactivation risk. Diagnosis is carried…
  • Abstract Number: 0631 • ACR Convergence 2020

    Clinical Manifestations and Outcomes in DMARD-Naïve Patients with Chronic Chikungunya Arthritis

    Nicolle Medina-Cintrón1, Idali Martínez1, Naydi Pérez-Ríos2, Yaritza Berríos-López2 and Luis Vilá3, 1University of Puerto Rico Medical Science Campus, San Juan, Puerto Rico, 2University of Puerto Rico Medical Sciences Campus, San Juan, Puerto Rico, 3University of Puerto Rico Medical Sciences Campus, San Juan

    Background/Purpose: Chikungunya virus (CHIKV) is characterized by fever, maculopapular rash, and severe polyarthralgia and polyarthritis.  Up to 80% of affected individuals may develop chronic CHIKV…
  • Abstract Number: 1469 • ACR Convergence 2020

    Characteristics of Adult Patients with Rheumatic Diseases During the COVID-19 Pandemic: Data from an International Patient Survey

    Jonathan Hausmann1, Kevin Kennedy2, Salman Surangiwala3, Maggie Larche4, Mitchell Levine2, Jean Liew5, Zachary Wallace6 and Emily Sirotich4, 1Boston Children's Hospital / Beth Israel Deaconess Medical Center, Cambridge, MA, 2McMaster University, Hamilton, Canada, 3Queen’s School of Medicine, Kingston, Canada, 4McMaster University, Hamilton, ON, Canada, 5University of Washington, Seattle, WA, 6Massachusetts General Hospital, Newton, MA

    Background/Purpose: Patients with rheumatic diseases are at increased risk of infection due to immune dysregulation and the use of immunosuppression.  It is unknown whether they…
  • Abstract Number: 0223 • ACR Convergence 2020

    Safety of Low Dose Methotrexate (MTX) and Tuberculosis (TB)

    Anna Davidson1, Alize Gunay1, Ines Colmegna2, Diane Lacaille3, Harold Loewen4, Michele Meltzer5, Yewondwossen Tadese6, Zenebe Yirsaw6, Sasha Bernatsky7 and Carol Hitchon4, 1McGill University, Montreal, QC, Canada, 2The Research Institute of the McGill University Health Centre, Montreal, Canada, 3University of British Columbia / Arthritis Research Canada, Richmond, BC, Canada, 4University of Manitoba, Winnipeg, MB, Canada, 5Jefferson University, Philadelphia, PA, 6Addis Ababa University, Addis Ababa, Adis Abeba, Ethiopia, 7The Research Institute of the McGill University Health Centre, Montreal, ON, Canada

    Background/Purpose: Increased awareness of the importance of MTX in rheumatic disease is leading to more MTX use in patients from TB-endemic areas.  Current management guidelines…
  • Abstract Number: 0632 • ACR Convergence 2020

    Systems Approach to Understanding Reasons for Influenza Vaccine Hesitancy in Rheumatic Diseases

    Valeria Valerio1, Mariana Useche1, Erin Field2, Mianbo Wang3, Elizabeth M. Hazel4, Brian Ward5 and Ines Colmegna1, 1The Research Institute of the McGill University Health Centre, Montreal, Canada, 2The Research Institute of the MUHC, Montreal, Canada, 3Lady Davis institute for Medical Research, Montreal, QC, Canada, 4McGill University Health Centre, Montreal, Canada, 5The Research Institute of the McGill University Health Centre, Monreal, QC, Canada

    Background/Purpose: A vaccination coverage goal of 80% with the seasonal influenza vaccine was established to protect people at high-risk for influenza-related complications or hospitalizations (e.g.…
  • Abstract Number: 1478 • ACR Convergence 2020

    A Multidisciplinary Registry of Patients with Autoinmune and Immune-Mediated Diseases with Symptomatic COVID-19 Infection from a Single Center

    Juan C Sarmiento-Monroy1, Gerard Espinosa2, Fernanda Meira1, Berta Caballol3, Maria C Londoño3, Sara Llufriu3, Aina Moll1, Luis Fernando Quintana Porras1, Felipe Julio Ramirez Garcia4, José Inciarte-Mundo1, Elisabeth Solana1, Yolanda Blanco1, Eugenia Martinez1, Victor Llorens1, Sergio Prieto-González5, Georgina Espigol1, Jose C Milisenda1, Maria C. Cid5, Priscila Giavedoni1, Jose M Mascaró1, Isabel Blanco1, Joan Albert Barbera1, Oriol Sibila1, Jordi Gratacos-Gines1, Alfredo Adan2, Alvaro Agustí1, Raimon Sanmartí6, Julián Panés1, Ricard Cervera1, Jordi Vila1, Alex Soriano1, Jose Gómez-Puerta6 and On behalf INMUNOCOVID CLINIC7, 1Hospital Clinic de Barcelona, Barcelona, Catalonia, Spain, 2Hospital Clinic, Barcelona, Catalonia, Spain, 3Hospital Clinic de Barcelona, Barcelona, Spain, 4Arthritis Unit, Rheumatology Dpt, Hospital Clinic, Barcelona, Spain, Barcelona, Catalonia, Spain, 5Vasculitis Research Unit, Department of Systemic Autoimmune Diseases, Hospital Clínic de Barcelona, IDIBAPS, University of Barcelona, Barcelona, Spain., Barcelona, Catalonia, Spain, 6Hospital Universitari Clínic de Barcelona, Barcelona, Catalonia, Spain, 7Hospital Clinic de Barcelona, Barcelona

    Background/Purpose: National health authorities reported a prevalence of SARS-CoV-2 infection around 7% of the general population in Barcelona county (1). A recent report focused on…
  • Abstract Number: 0227 • ACR Convergence 2020

    Real Life Severe Infections in Patients with Rheumatoid Arthritis on Treatment with Biological Therapy and JAK Inhibitors

    Lucía Vega-Álvarez1, Itziar Calvo-Zorrilla1, Oihane Ibarguengoitia-Barrena1, Juan M. Blanco-Madrigal1, David Montero-Seisdedos2, Carmen L. Garcia-Gomez1, Maria Esther Ruiz-Lucea1, Ana R. Inchaurbe-Pellejero1, Ignacio Torre-Salaberri1, Clara E. Perez-Velasquez1, Olaia Fernandez-Berrizbeitia1, Eduardo Cuende-Quintana3, Iñigo R. Gorostiza-Hormaetxe4, María Luz García-Vivar1 and Eva Galindez-Agirregoikoa1, 1Basurto University Hospital, BILBAO, Spain, 2Basurto University Hospital, Bilbao, Pais Vasco, Spain, 3Basurto University Hospital, Madrid, Spain, 4Basurto University Hospital, Bilbao

    Background/Purpose: Infections are one of the main complications among patients with rheumatoid arthritis (RA) with immunosuppressive treatment. The differences between treatments and the influence of…
  • Abstract Number: 0633 • ACR Convergence 2020

    Vitamin D Serum Status in a Cohort of COVID-19 Patients

    Alberto Sulli1, Emanuele Gotelli1, Sabrina Paolino1, Andrea Casabella1, Carmen Pizzorni1, Elisa Alessandri1, Vanessa Smith2 and Maurizio Cutolo1, 1Research Laboratory and Academic Division of Clinical Rheumatology, Department of Internal Medicine, University of Genova, IRCCS San Martino Polyclinic, Genoa, Italy, 2Department of Rheumatology, Ghent University Hospital, Department of Internal Medicine, VIB Inflammation Research Centre Ghent University, Ghent, Belgium

    Background/Purpose: Vitamin D serum levels have been inversely associated with risk of pulmonary infections and autoimmune inflammatory disease activity and severity [1,2]. A possible role…
  • Abstract Number: 1568 • ACR Convergence 2020

    Impact of the SARS-CoV-2 Pandemic on a Cohort of Patients with Rheumatic Complications of Immune Checkpoint Inhibitors: A Registry Survey Study

    Nilasha Ghosh1, Aidan Tirpack2, Caroline Benson3, Gregory Vitone3, Karmela Kim Chan2 and Anne Bass1, 1Hospital for Special Surgery/Weill Cornell Medicine, New York, NY, 2Hospital for Special Surgery, New York, NY, 3Hospital for Special Surgery, New York

    Background/Purpose: It is not known whether cancer patients being treated with immune checkpoint inhibitors (ICI) and/or immunosuppression are more vulnerable to SARS-CoV-2 or more apt…
  • « Previous Page
  • 1
  • …
  • 16
  • 17
  • 18
  • 19
  • 20
  • …
  • 32
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology